在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human coagulation factor Ⅶ,FⅦ ELISA Kit

  • 中文名稱:
    人凝血因子Ⅶ(FⅦ)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-E12909h
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人凝血因子Ⅶ(FⅦ)酶聯(lián)免疫試劑盒(CSB-E12909h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的F7含量。試劑盒檢測范圍為0.312 ng/mL-20 ng/mL,適用于凝血機(jī)制研究、抗凝藥物開發(fā)、肝病模型分析等科研領(lǐng)域,為心血管疾病和凝血功能障礙相關(guān)基礎(chǔ)研究提供高效工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    coagulation factor VII (serum prothrombin conversion accelerator) ELISA Kit; Coagulation factor VII ELISA Kit; Eptacog alfa ELISA Kit; F7 ELISA Kit; FA7_HUMAN ELISA Kit; Factor VII ELISA Kit; Factor VII heavy chain ELISA Kit; Factor VII light chain ELISA Kit; FVII coagulation protein ELISA Kit; OTTHUMP00000018733 ELISA Kit; OTTHUMP00000018734 ELISA Kit; Proconvertin ELISA Kit; Serum prothrombin conversion accelerator ELISA Kit; SPCA ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.312 ng/mL-20 ng/mL
  • 靈敏度:
    0.078 ng/mL
  • 反應(yīng)時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領(lǐng)域:
    Blood Coagulation
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human FⅦ in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
     SampleSerum(n=4)
    1:1000Average %92
    Range %87-95
    1:2000Average %104
    Range %99-107
    1:4000Average %92
    Range %85-96
    1:8000Average %97
    Range %93-100
  • 回收率:
    The recovery of human FⅦ spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9489-97
    EDTA plasma (n=4)9591-98
  • 標(biāo)準(zhǔn)曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    202.664 2.652 2.658 2.559
    102.341 2.302 2.322 2.223
    51.900 1.898 1.899 1.800
    2.51.120 1.132 1.126 1.027
    1.250.653 0.634 0.644 0.545
    0.6250.376 0.366 0.371 0.272
    0.3120.247 0.232 0.240 0.141
    00.101 0.097 0.099  
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評價

靶點(diǎn)詳情

  • 功能:
    Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
  • 基因功能參考文獻(xiàn):
    1. TF-FVIIa/trypsin-mediated PAR2 activation leads to enhanced MMP-2 expression in human breast cancer cells contributing to tumor progression. PMID: 29870887
    2. The current meta-analysis suggested that polymorphism of R353Q in factor VII was not associated with the MI risk. PMID: 30278561
    3. The obtained results suggest a possible protective role of Gln353 and -122C alleles in Recurrent Miscarriage. PMID: 27504943
    4. FVIIa-antithrombin levels in early and late preeclampsia PMID: 28887028
    5. model predicts that small vesicles promote activation of FX by the extrinsic tenase (VIIa/TF) significantly better than large vesicles PMID: 28935233
    6. Low levels of FVII:C and FVIIa reflected the degree of consumption of the coagulation factor among paediatric sepsis patients with disseminated intravascular coagulation. PMID: 28492702
    7. Report a good correlation between the type of F7 mutation and/or polymorphisms and FVII:C levels, without a direct link between FVII:C and bleeding tendency in factor VII deficiencies. PMID: 28447100
    8. Polymorphism rs6046 of the FVII gene is associated with the development of fetal growth retardation in Central Russia. PMID: 28544373
    9. A common pathogenic mechanism, possibly a defective folding of the mutant proteins, was triggered by the FVII mutations. The misfolded state led to impaired trafficking of these proteins causing Endoplasmic reticulum retention, which would explain the low to very low FVII plasma levels observed in patients carrying these mutations. PMID: 29246447
    10. FVIIa-antithrombin but not FVIIa is a ligand for LRP1, and LRP1 contributes to the clearance of FVIIa-antithrombin in vivo PMID: 27614059
    11. heterozygotes for FVII deficiency show rare bleeding manifestations which are also present in the unaffected family members with normal FVII levels. This indicates that Factor VII activity levels played no role in the occurrence of the bleeding symptoms. Furthermore, FVII levels of around 0.40 IU/dl are capable of assuring a normal hemostasis. PMID: 28176610
    12. plasma FVIIa-AT has a thrombophilic role in total and cardiovascular mortality risk in patients with clinically stable stable coronary artery PMID: 27061056
    13. Family-based association study revealed that the G allele of Protein Z rs2273971, and haplotypes GA, CG, and CGA of Protein Z and factor VII had a significant effect on cerebral hemorrhage susceptibility. PMID: 27350683
    14. Our study findings suggest a link between FVII and AR in prostate cancer pathogenesis. PMID: 27434295
    15. Suggest that the hemostatic effect of pharmacological doses of rFVIIa in antibody-induced hemophilia mice stems from a TF-independent mechanism PMID: 26727350
    16. Large deletions play a minor but essential role in the mutational spectrum of the F7 and F10 genes. Copy number analyses (e. g. MLPA) should be considered if sequencing cannot clarify the underlying reason of an observed coagulopathy. Of note, in cases of combined FVII/FX deficiency, a deletion of the two contiguous genes might be part of a larger chromosomal rearrangement. PMID: 26540129
    17. Holders of the R allele had significantly higher activity of coagulation factor F7 (97.66 +/- 15.48 against 83.37 +/- 15.16, p = 0.002) and factor F2 (107.45 +/- 6.03 against 103.75 +/- 6.81, p = 0.023) than holders of the Q allele PMID: 27215039
    18. The aim of the study was to evaluate the molecular basis behind low levels of FVII activity (FVII:C) levels in a cohort of Brazilian patients. PMID: 25828579
    19. Decreased plasma levels of FVIIa in patients with deep vein thrombosis may indicate ongoing consumption of FVIIa and suggest a contributory role for TF in venous thrombus formation. PMID: 25891834
    20. The story of FVII well summarizes the efforts of both theoretical and clinical approaches in the characterization of a coagulation disorder, that is, among the rare bleeding conditions, most frequently encountered in clinical practice. PMID: 25973586
    21. Identified are the FVII gene mutations in the Chinese Han population of four unrelated FVII-deficient patients, and the effect of these mutations on the function of FVII molecule level has also been elucidated. PMID: 25767893
    22. Letter: large volume of distribution of rFVIIa explains the persistence of some clotting potential when FVII:C is no longer detectable in plasma of patients with inherited FVII deficiency. PMID: 24763923
    23. Structural differences in the carboxyl-terminus between the inherited FVII and the therapeutic molecules contributed to the immune response. A naturally-occurring, poorly secreted and 5-residue truncated FVII (FVII-462X) escaped inhibition. PMID: 25104096
    24. Polymorphism R353Q (coagulation factor VII) does not represent a protective or risk factor for acute myocardial infarction in young Mexican individuals PMID: 25393858
    25. Two heterozygous mutations of F7, g.11349G>A and g.11482T>G, is associated with hereditary coagulation factor deficiency. PMID: 25863091
    26. factor VIIa improved heat intolerance by attenuating hypothalamic neuronal apoptosis and damage. PMID: 25033928
    27. Results show that the conformational allosteric activation signal extends to the EGF1 domain in the light chain of factor VIIa (FVIIa). PMID: 25344622
    28. F7-323Ins10 was associated with lower factor VII levels, but not with individual intraventricular hemorrhage risk in preterm infants. PMID: 25179312
    29. Decanucleotide insertion polymorphism of factor VII significantly influences the risk of thrombosis in patients with essential thrombocythemia. PMID: 24617727
    30. High Coagulation factor VII expression is associated with breast cancer. PMID: 25447311
    31. Persistently high levels of factor VII is associated with insulin resisitance. PMID: 24344794
    32. The variability in Factor VII throughout the menstrual cycle in premenopausal women is no greater than for postmenopausal women or men. PMID: 24382103
    33. The obtained results suggest a probable protective role of -323P10 allele against the risk of miscarriage in women with > or = 3 recurrent pregnancy losses. PMID: 25219139
    34. plasma level is associated with ischemic stroke subtypes PMID: 24048512
    35. Results suggest no association between R353Q polymorphism for factor VII and the presence or progression of coronary artery disease in the Iranian population. PMID: 24469878
    36. Identification of a homozygous mutation in exon 8 of coagulation FVII that is responsible for factor VII deficiency in a Chinese pedigree. PMID: 23672839
    37. Eight missense mutations were identified on the Factor 7 gene (p.Cys82Tyr, p.Cys322Ser, p.Leu357Phe, p.Thr410Ala, c-57C>T) PMID: 23731332
    38. Data indicate that nanobilayers containing phosphatidic acid (PA) bound substantially more of two proteins, factor VIIa and activated protein C, than did equivalent bilayers containing phosphatidylserine (PS). PMID: 23879866
    39. Data indicate that the interlaboratory precision was better for normal specimens than for factor VII (FVII) <20 U/dL with a mean coefficient of variation (CV) of 17.2% per specimen. PMID: 23590660
    40. Polymorphisms in the coagulation factor VII gene modulate the susceptibility to coronary artery disease in Tunisian Arabs. PMID: 22932775
    41. Rab GTPases regulate endothelial cell protein C receptor-mediated endocytosis and trafficking of factor VIIa. PMID: 23555015
    42. elevated FVII levels, and the -323P0/10 but not R353Q polymorphism, constitute risk factors for ACS. PMID: 23275237
    43. Data indicate that hfVII-LC and hIgG1-Fc can effectively inhibit tumor growth and metastases in SCID mice with tissue factor (TF) over-expressing colon cancer. PMID: 23494077
    44. Data suggest that plasma FVIIa-AT complex (coagulation factor VII-antithrombin III) is higher in portal vein thrombosis (PVT; without cirrhosis) than in healthy subjects; no difference in FVIIa-AT complex is observed in cirrhosis with/without PVT. PMID: 22958499
    45. Report comprehensive molecular analysis of FVII deficiency affected patients in North Tunisia. PMID: 22873696
    46. Prothromin genetic mutatation is one of the risk factor in the development of venous thromboembolism and myocardial infarction. PMID: 23382263
    47. glucose deprivation enhanced F7 expression in a mechanism reliant on prior ATF4 upregulation primarily due to increased transcription from the ATF4 gene. PMID: 22848420
    48. rs6046A allele in F7 associated with decreased blood pressure levels (PPMID: 22815813
    49. Intracellular depletion of GTP results in upregulation of coagulation factor VII. PMID: 23050902
    50. functional analysis of lethal factor VII deficiency due to novel mutations in the F7 promoter reveals disruption of HNF4 binding site PMID: 22628013

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Factor VII deficiency (FA7D)
  • 亞細(xì)胞定位:
    Secreted.
  • 蛋白家族:
    Peptidase S1 family
  • 組織特異性:
    Plasma.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 3544

    OMIM: 227500

    KEGG: hsa:2155

    STRING: 9606.ENSP00000364731

    UniGene: Hs.36989



主站蜘蛛池模板: 国产成人麻豆亚洲综合精品| 亚洲国产综合av在线观看| 天天摸天天做天天爽天天弄| 欧美va久久久噜噜噜久久| 少妇人妻真实偷人精品视频| 97se亚洲国产综合自在线观看 | 久久ee热这里只有精品| 成人影院yy111111| 国产精品无码制服丝袜| 久久99精品久久久久久齐齐| 少妇性荡欲视频| 国产精品毛片av999999| 乌克兰少妇xxxx做受野外| 无码av无码天堂资源网| av无码国产在线观看岛国| 欧美性xxxx极品hd欧美风情| 国产日产高清欧美一区| 亚洲中文无码永久免费| 欧美亚洲综合成人a∨在线 | 天天做天天爱夜夜夜爽毛片| 国产v综合v亚洲欧美久久| 日本欧美一区二区三区高清| 一本色道久久88亚洲精品综合| 亚洲日韩精品欧美一区二区| 欧美成 人版中文字幕| 中文字幕日产乱码国内自| 少妇人妻av无码专区| 国产精品香港三级国产av| 国内芒果精品自线一区2021| 国产免费一区二区三区在线观看| 精品国产乱码久久久久夜深人妻 | 137日本免费肉体摄影| 国产在热线精品视频| 欧美午夜精品一区二区三区电影| 华人在线亚洲欧美精品| 67194熟妇在线直接进入| 久久人人爽天天玩人人妻精品| 国产97超碰人人做人人爱| 无码纯肉动漫在线观看| 天天躁日日躁狠狠躁av麻豆男男 | 久久精品国产久精国产果冻传媒|